Cargando…

Phosphorylation, Signaling, and Cancer: Targets and Targeting

Detalles Bibliográficos
Autores principales:	Marmiroli, Sandra, Fabbro, Doriano, Miyata, Yoshihiko, Pierobon, Mariaelena, Ruzzene, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631856/ https://www.ncbi.nlm.nih.gov/pubmed/26576427 http://dx.doi.org/10.1155/2015/601543

Ejemplares similares

Lipids as Targets for Renal Cell Carcinoma Therapy
por: Stepanovska Tanturovska, Bisera, et al.
Publicado: (2023)

Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models
por: Baldelli, Elisa, et al.
Publicado: (2021)

Targeting Sphingosine Kinase 1 in Carcinoma Cells Decreases Proliferation and Survival by Compromising PKC Activity and Cytokinesis
por: Kotelevets, Nataliya, et al.
Publicado: (2012)

Correction: Targeting Sphingosine Kinase 1 in Carcinoma Cells Decreases Proliferation and Survival by Compromising PKC Activity and Cytokinesis
por: Kotelevets, Nataliya, et al.
Publicado: (2013)

Automated Classification of Lung Cancer Subtypes Using Deep Learning and CT-Scan Based Radiomic Analysis
por: Dunn, Bryce, et al.
Publicado: (2023)

Protein Phosphorylation in Cancer: Unraveling the Signaling Pathways
por: Coopman, Peter
Publicado: (2022)

Targeting CK2 in cancer: a valuable strategy or a waste of time?
por: Salvi, Mauro, et al.
Publicado: (2021)

Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells
por: Kreutzer, Jan N, et al.
Publicado: (2010)

Targeting cytoskeletal phosphorylation in cancer
por: Llorente-González, Clara, et al.
Publicado: (2021)

Target proteins reprogrammed by As and As + Si treatments in Solanum lycopersicum L. fruit
por: Marmiroli, Marta, et al.
Publicado: (2017)

Novel targeting approaches and signaling pathways of colorectal cancer: An insight
por: Tiwari, Ankita, et al.
Publicado: (2018)

PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases
por: Hillmann, Petra, et al.
Publicado: (2019)

Activation of Myosin Phosphatase Targeting Subunit by Mitosis-specific Phosphorylation
por: Totsukawa, Go, et al.
Publicado: (1999)

Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
por: Parasido, Erika Maria, et al.
Publicado: (2016)

Special Issue “The Genetic Changes Induced by Engineered Manufactured Nanomaterials (EMNs)”
por: Marmiroli, Marta
Publicado: (2022)

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors
por: Baldelli, Elisa, et al.
Publicado: (2015)

Targeting IL-11 signaling in colon cancer
por: Ernst, Matthias, et al.
Publicado: (2013)

Announcing Signal Transduction and Targeted Therapy
por: Croce, C M, et al.
Publicado: (2016)

Targeting Danger Signals to Rescue Fibrosis
por: Tsoyi, Konstantin, et al.
Publicado: (2022)

The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer
por: Floc'h, Nicolas, et al.
Publicado: (2012)

Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer
por: Holzmann, Klaus, et al.
Publicado: (2019)

Protein kinase CK2: a potential therapeutic target for diverse human diseases
por: Borgo, Christian, et al.
Publicado: (2021)

Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells
por: Blain, Stacy W.
Publicado: (2018)

Dopamine signaling: target in glioblastoma
por: Bartek, Jiri, et al.
Publicado: (2014)

Rosamines Targeting the Cancer Oxidative Phosphorylation Pathway
por: Lim, Siang Hui, et al.
Publicado: (2014)

Targeting parallel bypass signaling to combat adaptive resistance to BRAF inhibition in colorectal cancer
por: Gao, Chenxi, et al.
Publicado: (2018)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

Targeted cancer therapies
por: Yan, Li, et al.
Publicado: (2011)

Targeting in Cancer Therapies
por: Mangues, Ramon, et al.
Publicado: (2016)

Targeted therapies for cancer
por: Zhou, Zhijun, et al.
Publicado: (2022)

GABA Signaling: Therapeutic Targets for Neurodegenerative and Neurodevelopmental Disorders
por: Cherubini, Enrico, et al.
Publicado: (2023)

Phosphorylation of p23-1 cochaperone by protein kinase CK2 affects root development in Arabidopsis
por: D’Alessandro, Stefano, et al.
Publicado: (2019)

The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131
por: Vilardell, Jordi, et al.
Publicado: (2018)

Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells
por: Zanin, Sofia, et al.
Publicado: (2012)

Known Antimicrobials Versus Nortriptyline in Candida albicans: Repositioning an Old Drug for New Targets
por: Caldara, Marina, et al.
Publicado: (2020)

Targeting Tyrosine Kinases in Cancer: Lessons for an Effective Targeted Therapy in the Clinic
por: Angelucci, Adriano
Publicado: (2019)

Targeting NFκB signaling in GD2(+) BCSCs
por: Nguyen, Khoa, et al.
Publicado: (2017)

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer
por: Wall, Jaclyn A., et al.
Publicado: (2020)

Targeting Bcl2 in cancer
por: Chen, Guo, et al.
Publicado: (2015)

Different cancers, same target?
por: Villegas, Jaime, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i9uaqkdssre8jcmu4lnr3s00as